|
Aug 13
|
Mizuho Raises PT on ICON Public Limited Company (ICLR) to $225; Maintains ‘Outperform’ Rating
|
|
Aug 12
|
ICON (ICLR) Fell Along with Broader CROs
|
|
Aug 11
|
ICON plc (ICLR) Fell due to Persistent Volatility in the Clinical Development Market
|
|
Jul 28
|
ICON Public Limited Company (NASDAQ:ICLR) Shares Could Be 33% Below Their Intrinsic Value Estimate
|
|
Jul 24
|
Sector Update: Health Care Stocks Softer in Afternoon Trading
|
|
Jul 23
|
ICON Announces Results of Annual General Meeting
|
|
Jul 23
|
ICON Reports Second Quarter 2025 Results
|
|
Jul 16
|
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
|
|
Jul 15
|
Do You Believe in the Upside Potential of ICON PLC (ICLR)?
|
|
Jul 7
|
Despite delivering investors losses of 53% over the past 1 year, ICON (NASDAQ:ICLR) has been growing its earnings
|
|
Jul 7
|
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
|
|
Jul 7
|
Clearbridge Large Cap Growth Strategy Sold Its Stake in ICON Public Limited Company (ICLR)
|
|
Jul 3
|
Will ICON PLC (ICLR) Benefit from R&D Spending?
|
|
Jun 26
|
Should You Hold ICON PLC (ICLR)?
|
|
Jun 23
|
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
|
|
May 27
|
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
|
|
Apr 27
|
ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now
|
|
Apr 24
|
Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 23
|
Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
|
|
Apr 23
|
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
|